Inventor

BUCALA RICHARD J

US51 patents

⚠️ This page may combine multiple inventors who share the name “BUCALA RICHARD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BUCALA RICHARD J

PICOWER INST MED RES

Blood-borne mesenchymal cells

Combination method for treating diseases caused by cytokine-mediated toxicity

Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts

Immunological advanced glycation endproduct crosslink

Blood-borne mesenchymal cells

Modulation of immune responses in blood-borne mesenchymal cells

Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom

Blood-borne mesenchymal cells

Blood-borne mesenchymal cells

Methods and materials for the diagnosis and treatment of conditions such as stroke

Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom

Methods and materials for the diagnosis and treatment of conditions such as stroke

Methods and materials for the diagnosis and treatment of conditions such as stroke

Methods and materials for the diagnosis and treatment of conditions such as stroke

Composition containing anti-MIF antibody

Inducible phosphofructokinase and the Warburg effect

Diagnostic assays for MIF

Compounds having MIF antagonist activity

Methods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts

Vaccine adjuvant

Advanced glycosylation endproducts and methods of use therefor

Inducible phosphofructokinase and the warburg effect

Method and agents for inhibiting protein aging

Inducible phosphofructokinase and the Warburg effect

Method and agents for inhibiting protein aging

Fibrocyte-base vaccine formulations

Tobacco combination product filter

UNIV ROCKEFELLER

Immunochemical detection of in vivo advanced glycosylation endproducts

Antibodies to in vivo advanced glycosylation endproducts

Immunochemical detection of in vivo advanced glycosylation endproducts

Immunochemical detection of In vivo advanced glycosylation end products

Immunochemical detection of in vivo advanced glycosylation endproducts

Immunochemical isolation of in vivo advanced glycosylation endproducts

CYTOKINE PHARMASCIENCES INC

Therapeutic uses of factors which inhibit or neutralize MIF activity

Method for determining MIF content

Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor

ALTEON INC

Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts

Method for detecting hemoglobin advanced glycosylation endproducts

Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts

UNIV YALE

MIF modulators

MIF modulators

JORGENSEN WILLIAM L

MIF modulators

MIF modulators

BUCALA RICHARD J

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

MIF antagonists

BAXTER INT

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease

(unassigned)

Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis

PICOWER INST OF MEDICAL RES

Compounds having MIF antagonist activity

LONG ISLAND JEWISH RES INST

Compounds and compositions for treating tissue ischemia